These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8632435)

  • 1. An NMR, CD, molecular dynamics, and fluorometric study of the conformation of the bradykinin antagonist B-9340 in water and in aqueous micellar solutions.
    Sejbal J; Cann JR; Stewart JM; Gera L; Kotovych G
    J Med Chem; 1996 Mar; 39(6):1281-92. PubMed ID: 8632435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proton magnetic resonance study of two synthetic agonist-antagonist pairs of bradykinin analogues.
    Otter A; Bigler P; Stewart JM; Kotovych G
    Biopolymers; 1993 May; 33(5):769-80. PubMed ID: 8393713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CD and an NMR study of multiple bradykinin conformations in aqueous trifluoroethanol solutions.
    Cann JR; Liu X; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1994 Jul; 34(7):869-78. PubMed ID: 8054469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of the N-terminal beta-turn in bradykinin antagonists.
    Miskolzie M; Gera L; Stewart JM; Kotovych G
    J Biomol Struct Dyn; 2000 Oct; 18(2):249-60. PubMed ID: 11089646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance studies of bradykinin antagonists.
    Liu X; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1993 Aug; 33(8):1237-47. PubMed ID: 8364157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational studies of two bradykinin antagonists by using two-dimensional NMR techniques and molecular dynamics simulations.
    Sikorska Trzepałka E; Slusarz R; Lammek B
    J Biomol Struct Dyn; 2005 Oct; 23(2):125-34. PubMed ID: 16060686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative NMR and molecular dynamics study of the conformations of bradykinin B1 and B2, B2, and B1-specific receptor antagonists B-9430, B-9436, and B-9858.
    Sejbal J; Wang Y; Cann JR; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1997 Oct; 42(5):521-35. PubMed ID: 9322442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aggregation properties of some bradykinin analogs.
    Liu X; Stewart JM; Cann JR; Gera L; Kotovych G
    J Biomol Struct Dyn; 1993 Aug; 11(1):169-79. PubMed ID: 8216942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a micellar environment on the conformations of two cyclic pentapeptides.
    Bruch MD; Rizo J; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1741-54. PubMed ID: 1472656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity.
    Miskolzie M; Gera L; Stewart JM; Kotovych G
    J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An NMR conformational analysis of cyclic bradykinin mimics. Evidence for a beta-turn.
    Miskolzie M; Yamamoto H; York EJ; Stewart JM; Kotovych G
    J Biomol Struct Dyn; 2000 Jun; 17(6):947-55. PubMed ID: 10949162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Threonine6-bradykinin: molecular dynamics simulations in a biphasic membrane mimetic.
    Pellegrini M; Mierke DF
    J Med Chem; 1997 Jan; 40(1):99-104. PubMed ID: 9016333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution conformations of bradykinin antagonists modified with Calpha-Calpha cyclized nonaromatic residues.
    Sikorska E; Rodziewicz-Motowidło S
    J Pept Sci; 2008 Jul; 14(7):819-29. PubMed ID: 18219704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of bradykinin conformation in a dimethylsulfoxide solution by two-dimensional 1H-NMR spectroscopy].
    Saulitis IuB; Liepin'sh EE; Sekatsis IP; Mutulis FK; Chipens GI
    Bioorg Khim; 1986 Apr; 12(4):437-47. PubMed ID: 3718546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational analysis of the highly potent bradykinin antagonist Hoe-140 by means of two different computational methods.
    Filizola M; Centeno NB; Cartení-Farina M; Perez JJ
    J Biomol Struct Dyn; 1998 Feb; 15(4):639-52. PubMed ID: 9514242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nmr and molecular modeling investigations of the neuropeptide bradykinin in three different solvent systems: DMSO, 9:1 dioxane/water, and in the presence of 7.4 mM lyso phosphatidylcholine micelles.
    Young JK; Hicks RP
    Biopolymers; 1994 May; 34(5):611-23. PubMed ID: 8003621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conformation-activity relations of des-Arg9-bradykinin. I. Conformation of molecules in solution].
    Shenderovich MD
    Bioorg Khim; 1989 Sep; 15(9):1173-84. PubMed ID: 2590252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of increased length and intact capping sequences to the conformational preference for helix in a 31-residue peptide from the C terminus of myohemerythrin.
    Reymond MT; Huo S; Duggan B; Wright PE; Dyson HJ
    Biochemistry; 1997 Apr; 36(17):5234-44. PubMed ID: 9136885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional structure of neuropeptide k bound to dodecylphosphocholine micelles.
    Dike A; Cowsik SM
    Biochemistry; 2006 Mar; 45(9):2994-3004. PubMed ID: 16503654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-induced secondary structures of neuropeptides: a comparison of the solution conformations adopted by agonists and antagonists of the mammalian tachykinin NK1 receptor.
    Whitehead TL; McNair SD; Hadden CE; Young JK; Hicks RP
    J Med Chem; 1998 Apr; 41(9):1497-506. PubMed ID: 9554882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.